Rush Enterprises, Inc. Reports First Quarter 2020 Results, Announces $0.13 Per Share Dividend
April 22, 2020 17:43 ET
|
Rush Enterprises, Inc.
Revenues of $1.287 billion, net income of $23.1 millionEarnings per diluted share of $0.62Absorption ratio 114.3%Board declares cash dividend of $0.13 per share of Class A and Class B common...
Stryker announces definitive agreement to acquire Entellus
December 07, 2017 08:15 ET
|
Stryker Corporation
Kalamazoo, Michigan - December 7, 2017 - Stryker Corporation (NYSE: SYK) announced today a definitive merger agreement to acquire Entellus Medical, Inc. (NASDAQ: ENTL) for $24.00 per share, or an...
Entellus Medical Announces Third Quarter 2017 Financial Results
November 01, 2017 16:05 ET
|
Entellus Medical, Inc.
PLYMOUTH, Minn., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering less invasive ENT products, today reported its financial...
Entellus Medical Announces Second Quarter 2017 Financial Results
August 03, 2017 16:03 ET
|
Entellus Medical, Inc.
PLYMOUTH, Minn., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through...
Entellus Medical Announces First Quarter 2017 Financial Results
May 03, 2017 16:03 ET
|
Entellus Medical, Inc.
PLYMOUTH, Minn., May 03, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ: ENTL), a medical technology company focused on delivering superior patient and physician experiences through...
Entellus Medical Announces Fourth Quarter and Full Year 2016 Financial Results
February 21, 2017 16:03 ET
|
Entellus Medical, Inc.
PLYMOUTH, Minn., Feb. 21, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through...
Entellus Medical Announces Pricing of Public Offering of Common Stock
January 25, 2017 21:00 ET
|
Entellus Medical, Inc.
PLYMOUTH, Minn., Jan. 25, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (the “Company” or “Entellus Medical”) (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and...
Entellus Medical Announces Proposed Public Offering of Common Stock
January 25, 2017 16:45 ET
|
Entellus Medical, Inc.
PLYMOUTH, Minn., Jan. 25, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (the “Company” or “Entellus Medical”) (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and...
National Institute for Health and Care Excellence (NICE) Provides Positive Guidance for Use of the XprESS Multi-Sinus Dilation System for Treating Chronic Sinusitis
December 13, 2016 09:29 ET
|
Entellus Medical, Inc.
PLYMOUTH, Minn., Dec. 13, 2016 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through...
Entellus Medical Announces Publication of Positive Clinical Data for XprESS for Treatment of Pediatric Chronic Rhinosinusitis
November 29, 2016 08:46 ET
|
Entellus Medical, Inc.
PLYMOUTH, Minn., Nov. 29, 2016 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through...